[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Gemcitabine Hydrochloride Market Research Report Forecast 2017-2021

March 2017 | 120 pages | ID: U8183613F35EN
S&P Consulting

US$ 2,960.00 US$ 3,700.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The United States Gemcitabine Hydrochloride Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Gemcitabine Hydrochloride industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Gemcitabine Hydrochloride market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
The Major players reported in the market include:

AFINE CHEMICALS
Arch Pharmalabs
Eli Lilly
Fresenius Kabi
INTAS PHARMACEUTICALS
JARI PHARMACEUTICAL
Jiangsu Hansoh
NINGBO TEAM
ScinoPharm Taiwan

United States Gemcitabine Hydrochloride Market: Product Segment Analysis

Type 1
Type 2
Type 3

United States Gemcitabine Hydrochloride Market: Application Segment Analysis

Lung Cancer
Pancreatic Cancer
Bladder Cancer

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
United States Gemcitabine Hydrochloride Market Research Report Forecast 2017-2021

CHAPTER 1 GEMCITABINE HYDROCHLORIDE MARKET OVERVIEW

1.1 Product Overview and Scope of Gemcitabine Hydrochloride
1.2 Gemcitabine Hydrochloride Market Segmentation by Type
  1.2.1 United States Production Market Share of Gemcitabine Hydrochloride by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Gemcitabine Hydrochloride Market Segmentation by Application
  1.3.1 Gemcitabine Hydrochloride Consumption Market Share by Application in 2015
  1.3.2 Lung Cancer
  1.3.3 Pancreatic Cancer
  1.3.4 Bladder Cancer
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Gemcitabine Hydrochloride (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON GEMCITABINE HYDROCHLORIDE INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES GEMCITABINE HYDROCHLORIDE MARKET COMPETITION BY MANUFACTURERS

3.1 United States Gemcitabine Hydrochloride Production and Share by Manufacturers (2015 and 2016)
3.2 United States Gemcitabine Hydrochloride Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Gemcitabine Hydrochloride Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Gemcitabine Hydrochloride Manufacturing Base Distribution, Production Area and Product Type
3.5 Gemcitabine Hydrochloride Market Competitive Situation and Trends
  3.5.1 Gemcitabine Hydrochloride Market Concentration Rate
  3.5.2 Gemcitabine Hydrochloride Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES GEMCITABINE HYDROCHLORIDE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Gemcitabine Hydrochloride Production and Market Share by Type (2012-2017)
4.2 United States Gemcitabine Hydrochloride Revenue and Market Share by Type (2012-2017)
4.3 United States Gemcitabine Hydrochloride Price by Type (2012-2017)
4.4 United States Gemcitabine Hydrochloride Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES GEMCITABINE HYDROCHLORIDE MARKET ANALYSIS BY APPLICATION

5.1 United States Gemcitabine Hydrochloride Consumption and Market Share by Application (2012-2017)
5.2 United States Gemcitabine Hydrochloride Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES GEMCITABINE HYDROCHLORIDE MANUFACTURERS ANALYSIS

6.1 AFINE CHEMICALS
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 Arch Pharmalabs
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Eli Lilly
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Fresenius Kabi
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 INTAS PHARMACEUTICALS
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 JARI PHARMACEUTICAL
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Jiangsu Hansoh
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 NINGBO TEAM
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 ScinoPharm Taiwan
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 GEMCITABINE HYDROCHLORIDE MANUFACTURING COST ANALYSIS

7.1 Gemcitabine Hydrochloride Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gemcitabine Hydrochloride

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Gemcitabine Hydrochloride Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gemcitabine Hydrochloride Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES GEMCITABINE HYDROCHLORIDE MARKET FORECAST (2017-2021)

11.1 United States Gemcitabine Hydrochloride Production, Revenue Forecast (2017-2021)
11.2 United States Gemcitabine Hydrochloride Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Gemcitabine Hydrochloride Production Forecast by Type (2017-2021)
11.4 United States Gemcitabine Hydrochloride Consumption Forecast by Application (2017-2021)
11.5 Gemcitabine Hydrochloride Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Gemcitabine Hydrochloride
Table Classification of Gemcitabine Hydrochloride
Figure United States Sales Market Share of Gemcitabine Hydrochloride by Type in 2015
Table Application of Gemcitabine Hydrochloride
Figure United States Sales Market Share of Gemcitabine Hydrochloride by Application in 2015
Figure United States Gemcitabine Hydrochloride Sales and Growth Rate (2011-2021)
Figure United States Gemcitabine Hydrochloride Revenue and Growth Rate (2011-2021)
Table United States Gemcitabine Hydrochloride Sales of Key Manufacturers (2015 and 2016)
Table United States Gemcitabine Hydrochloride Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Gemcitabine Hydrochloride Sales Share by Manufacturers
Figure 2016 Gemcitabine Hydrochloride Sales Share by Manufacturers
Table United States Gemcitabine Hydrochloride Revenue by Manufacturers (2015 and 2016)
Table United States Gemcitabine Hydrochloride Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Gemcitabine Hydrochloride Revenue Share by Manufacturers
Table 2016 United States Gemcitabine Hydrochloride Revenue Share by Manufacturers
Table United States Market Gemcitabine Hydrochloride Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Gemcitabine Hydrochloride Average Price of Key Manufacturers in 2015
Figure Gemcitabine Hydrochloride Market Share of Top 3 Manufacturers
Figure Gemcitabine Hydrochloride Market Share of Top 5 Manufacturers
Table United States Gemcitabine Hydrochloride Sales by Type (2012-2017)
Table United States Gemcitabine Hydrochloride Sales Share by Type (2012-2017)
Figure United States Gemcitabine Hydrochloride Sales Market Share by Type in 2015
Table United States Gemcitabine Hydrochloride Revenue and Market Share by Type (2012-2017)
Table United States Gemcitabine Hydrochloride Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gemcitabine Hydrochloride by Type (2012-2017)
Table United States Gemcitabine Hydrochloride Price by Type (2012-2017)
Figure United States Gemcitabine Hydrochloride Sales Growth Rate by Type (2012-2017)
Table United States Gemcitabine Hydrochloride Sales by Application (2012-2017)
Table United States Gemcitabine Hydrochloride Sales Market Share by Application (2012-2017)
Figure United States Gemcitabine Hydrochloride Sales Market Share by Application in 2015
Table United States Gemcitabine Hydrochloride Sales Growth Rate by Application (2012-2017)
Figure United States Gemcitabine Hydrochloride Sales Growth Rate by Application (2012-2017)
Table AFINE CHEMICALS Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AFINE CHEMICALS Gemcitabine Hydrochloride Production, Revenue, Price and Gross Margin (2012-2017)
Table AFINE CHEMICALS Gemcitabine Hydrochloride Market Share (2012-2017)
Table Arch Pharmalabs Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Arch Pharmalabs Gemcitabine Hydrochloride Production, Revenue, Price and Gross Margin (2012-2017)
Table Arch Pharmalabs Gemcitabine Hydrochloride Market Share (2012-2017)
Table Eli Lilly Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eli Lilly Gemcitabine Hydrochloride Production, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly Gemcitabine Hydrochloride Market Share (2012-2017)
Table Fresenius Kabi Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Fresenius Kabi Gemcitabine Hydrochloride Production, Revenue, Price and Gross Margin (2012-2017)
Table Fresenius Kabi Gemcitabine Hydrochloride Market Share (2012-2017)
Table INTAS PHARMACEUTICALS Basic Information, Manufacturing Base, Production Area and Its Competitors
Table INTAS PHARMACEUTICALS Gemcitabine Hydrochloride Production, Revenue, Price and Gross Margin (2012-2017)
Table INTAS PHARMACEUTICALS Gemcitabine Hydrochloride Market Share (2012-2017)
Table JARI PHARMACEUTICAL Basic Information, Manufacturing Base, Production Area and Its Competitors
Table JARI PHARMACEUTICAL Gemcitabine Hydrochloride Production, Revenue, Price and Gross Margin (2012-2017)
Table JARI PHARMACEUTICAL Gemcitabine Hydrochloride Market Share (2012-2017)
Table Jiangsu Hansoh Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Jiangsu Hansoh Gemcitabine Hydrochloride Production, Revenue, Price and Gross Margin (2012-2017)
Table Jiangsu Hansoh Gemcitabine Hydrochloride Market Share (2012-2017)
Table NINGBO TEAM Basic Information, Manufacturing Base, Production Area and Its Competitors
Table NINGBO TEAM Gemcitabine Hydrochloride Production, Revenue, Price and Gross Margin (2012-2017)
Table NINGBO TEAM Gemcitabine Hydrochloride Market Share (2012-2017)
Table ScinoPharm Taiwan Basic Information, Manufacturing Base, Production Area and Its Competitors
Table ScinoPharm Taiwan Gemcitabine Hydrochloride Production, Revenue, Price and Gross Margin (2012-2017)
Table ScinoPharm Taiwan Gemcitabine Hydrochloride Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gemcitabine Hydrochloride
Figure Manufacturing Process Analysis of Gemcitabine Hydrochloride
Figure Gemcitabine Hydrochloride Industrial Chain Analysis
Table Raw Materials Sources of Gemcitabine Hydrochloride Major Manufacturers in 2015
Table Major Buyers of Gemcitabine Hydrochloride
Table Distributors/Traders List
Figure United States Gemcitabine Hydrochloride Production and Growth Rate Forecast (2017-2021)
Figure United States Gemcitabine Hydrochloride Revenue and Growth Rate Forecast (2017-2021)
Table United States Gemcitabine Hydrochloride Production Forecast by Type (2017-2021)
Table United States Gemcitabine Hydrochloride Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

AFINE CHEMICALS, Arch Pharmalabs, Eli Lilly, Fresenius Kabi, INTAS PHARMACEUTICALS, JARI PHARMACEUTICAL, Jiangsu Hansoh, NINGBO TEAM, ScinoPharm Taiwan, Sun Pharmaceutical, Sunray Pharmaceutical, Tecoland, Teva Group, Zhejiang Hisun


More Publications